Global Nutrigenomics Testing Market is Projected to Grow at a CAGR of 17.2% and Generate a Revenue of $ 2108.00 million by 2032

The nutrigenomics market size was $ 435.70 million in 2022 and is predicted to grow with a CAGR of 17.2%, by generating a revenue of $ 2108.00 million by 2032.

Impact Analysis of COVID-19 on the Nutrigenomics Testing Market

In recent years, nutrigenomics testing has become a popular trend, and the COVID-19 pandemic has highlighted its adoption. As individuals were looking for new ways to monitor their health from their homes, nutrigenomics testing became a popular solution during the pandemic.

The COVID-19 pandemic has brought personal health to the forefront of many people's minds, and direct-to-consumer (DTC) wellness testing has been one of the most significant responses to this shift in priorities. The demand for at-home health tests has increased rapidly, allowing individuals to monitor their health quickly and easily from their homes. With the advent of new technologies, nutrigenomics tests are becoming increasingly accurate and advanced, offering a range of options for testing from genetic predispositions to nutrition levels.

Global Nutrigenomics Testing Market Analysis

Precision medicine is expected to increase the demand for nutrigenomics testing across the globe. It has also led to the growth of telehealth and research services offered by major companies such as 23andMe, Inc. and Ancestry. Telehealth enables consumers to access healthcare conveniently, from their homes, and to obtain fast and affordable consultation, diagnosis, and treatment without the difficulties of scheduling appointments and traveling to physical locations. By accessing medical consultation and treatment through telehealth platform, patients are able to take ownership of their health. Furthermore, support and demand for telehealth services have been increasing due to deregulation and broad societal shifts. In addition, many companies are building their own telehealth platforms for providing personalized consultation and reports. For instance, Lemonaid Health by 23andMe, Inc. is a telehealth platform that provides affordable and direct online access to medical care, from consultation through treatment, by connecting patients to licensed healthcare professionals for certain genetic reports. Such innovative healthcare models are projected to boost the market growth for nutrigenomics testing in the future.

Reliability on third party suppliers acts as restraining factor for the nutrigenomics market as many companies within the market do not have manufacturing capabilities and any further plans to develop such capacity in the future. Manufacturers generally rely on third-party suppliers to attain materials such as saliva collection kits, bead chips, reagents or other materials and equipment used in laboratory operations and services. Therefore, change in the supplier or design of certain materials which the manufacturers rely on, in particular the bead chip and saliva collection kit, could result in the need for additional premarket review from the Food and Drug Administration (FDA). Furthermore, the nutrigenomics testing companies are required to validate any new laboratory or laboratories in accordance with the FDA standards prior to utilizing their services for their customers. These are the major factors projected to hamper the market revenue growth during the forecast period.

Nutrigenomics companies are utilizing emerging technologies such as artificial intelligence (AI), for providing better nutrigenomics testing services. In addition, AI is a rapidly evolving technology and hence it can be used to analyze large sets of nutritional and genetic data, also help in identifying various patterns and relationships, and generate personalized dietary recommendations based on the information. Thus, the integration of AI in nutrigenomics testing has enormous potential to transition the field of nutrigenomics. For instance, it can help to identify the specific genes and genetic variations that influence human bodies and their response to different nutrients. This information can then be used to develop more targeted and effective dietary recommendations, tailored to an individual’s unique genetic profile.

Global Nutrigenomics Testing Market, Segmentation

The nutrigenomics testing market is segmented on the basis of application, product, end user, and region.

Application:

The application segment is classified obesity, diabetes, cardiovascular diseases, and cancer research. Among these, the obesity sub-segment is anticipated to be the fastest growing during the forecast period. The rate of obesity is increasing due to higher dietary energy intake and unhealthy lifestyle. Also, obesity is influenced by many other factors such as environmental, behavioral, hormonal, metabolic, and genetic predisposition. It is believed that genes, environmental factors such as dietary nutrients intake, and their interactions affect obesity. Hence it is important to follow a healthy diet and seek personalized nutrition for the effective prevention and treatment of obesity. Thus, obesity will increase the need to personalized nutrition which in turn will generate the demand for nutrigenomics testing.

Product:

The product segment is further classified into reagents & kits and services. Among these, the reagents & kits sub-segment is projected to witness the highest CAGR during the forecast years, as number of home DNA test kits offering nutrition and diet advice matching to specific individual is growing. These tests are based on the idea that each individual responds to different foods in a different manner depending on individual nutritional needs and unique genetic make-up. Hence, consumers are preferring personalized diets suggested by doctor or dietitian. Furthermore, home-based nutrigenomic testing is even more accentuated due to the adoption of telehealth services which in turn is anticipated to generate a demand for nutrigenomic testing in the future.

End User:

The end user segment is further classified into online platforms, hospitals & clinics, and others. Among these, the online platforms sub-segment is predicted to have the fastest growth during the forecast period. Popularity of online platforms is rising as telehealth is revolutionizing the healthcare sector since the COVID-19 pandemic. According 2021 Telehealth Survey Report by American Medical Association, 85% of physician respondents indicate they currently use telehealth and 60% of clinicians agree or strongly agree telehealth enabled them to provide high quality care. Using telehealth services people can get virtual access to all the healthcare services such as doctors’ consultation or advice, medication, personalized diet plans, and others. Therefore, the online platforms sub-segment in the nutrigenomics testing market is anticipated to grow at a faster pace in the future.

Region:

The nutrigenomics testing market in North America is projected to show the fastest growth during the forecast period. North America is a home for several giant nutrigenomics companies such as Ancestry.com LLC, 23andME Holding Co., Nutrigenomix, GX Sciences Inc., and others. Furthermore, the prevalence of chronic diseases is rising at faster pace in the region, which is again generating the demand for nutrigenomics testing. Consumers in this region are shifting their preferences towards more tailor-made diets and health eating habits, which is expected to boost the market of nutrigenomics testing in the future.

Key Players in the Global Nutrigenomics Testing Market

Some of the companies operating in the nutrigenomics testing market are Ancestry, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., Xcode Life, Koninklijke DSM N.V. (Royal DSM), BASF SE, Danone S.A., and The Gene Box.